全文获取类型
收费全文 | 11645篇 |
免费 | 542篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 195篇 |
儿科学 | 361篇 |
妇产科学 | 282篇 |
基础医学 | 1717篇 |
口腔科学 | 364篇 |
临床医学 | 976篇 |
内科学 | 1974篇 |
皮肤病学 | 263篇 |
神经病学 | 1048篇 |
特种医学 | 640篇 |
外国民族医学 | 5篇 |
外科学 | 1773篇 |
综合类 | 41篇 |
一般理论 | 4篇 |
预防医学 | 520篇 |
眼科学 | 386篇 |
药学 | 811篇 |
中国医学 | 22篇 |
肿瘤学 | 817篇 |
出版年
2023年 | 57篇 |
2021年 | 120篇 |
2020年 | 88篇 |
2019年 | 133篇 |
2018年 | 286篇 |
2017年 | 211篇 |
2016年 | 278篇 |
2015年 | 238篇 |
2014年 | 307篇 |
2013年 | 375篇 |
2012年 | 650篇 |
2011年 | 598篇 |
2010年 | 321篇 |
2009年 | 242篇 |
2008年 | 535篇 |
2007年 | 543篇 |
2006年 | 527篇 |
2005年 | 513篇 |
2004年 | 511篇 |
2003年 | 450篇 |
2002年 | 491篇 |
2001年 | 373篇 |
2000年 | 406篇 |
1999年 | 346篇 |
1998年 | 78篇 |
1997年 | 55篇 |
1996年 | 67篇 |
1992年 | 164篇 |
1991年 | 149篇 |
1990年 | 164篇 |
1989年 | 143篇 |
1988年 | 150篇 |
1987年 | 152篇 |
1986年 | 152篇 |
1985年 | 151篇 |
1984年 | 103篇 |
1983年 | 105篇 |
1982年 | 61篇 |
1981年 | 58篇 |
1979年 | 142篇 |
1978年 | 76篇 |
1977年 | 82篇 |
1975年 | 61篇 |
1974年 | 71篇 |
1973年 | 83篇 |
1972年 | 70篇 |
1971年 | 65篇 |
1970年 | 71篇 |
1969年 | 59篇 |
1968年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
1.
2.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
3.
4.
5.
6.
Dorit Gräbsch 《MedR Medizinrecht》2006,24(1):VI-VIII
Ohne Zusammenfassung 相似文献
7.
Dorit Gräbsch 《MedR Medizinrecht》2006,24(4):VI-VIII
Ohne Zusammenfassung 相似文献
8.
I Immonen K Friberg C Gr?nhagen-Riska E von Willebrand F Fyhrquist 《Acta ophthalmologica》1986,64(5):519-521
Angiotensin-converting enzyme (ACE) was studied immunohistochemically in conjunctival biopsies from 6 patients with systemic sarcoidosis, 4 patients with posterior non-sarcoid uveitis and in specimens from 4 patients with chalazion of the eyelid. Specimens with sarcoid granulomas showed intense ACE-positive immunoreactivity in epitheloid cells of the granuloma, whereas chalazion granulomas did not contain ACE-immunoreactivity. There was no difference in staining patterns between specimens without granulomas. Thus immunohistochemical staining for ACE may be of help in differentiating conjunctival granulomatous tissue of a chalazion from sarcoid granuloma. 相似文献
9.
10.
AIM: To report the treatment of a recurrent adenoid-cystic carcinoma of the lacrimal gland required orbital exenteration with an en bloc resection of the lateral orbital rim and wall and an anterior portion of the temporal muscle. Reconstruction was planned with both the objectives of a shortened healing time for faster epithetic reconstruction and no visible scars. METHOD: After a cranially extended temporal approach, the dissection of the superficial galea layer was connected with the subcutaneous dissection of the upper and lower eyelid after subciliary incisions. RESULTS: Ample exposure of the temporal, frontal and orbital region was obtained, facilitating the orbital exenteration with en bloc resection of the lateral orbital rim and wall and the anterior portion of the temporal muscle. The epithelialization of the eye socket covered with the galea fascia flap was accelerated, providing faster epithetic reconstruction, without visible scars. CONCLUSIONS: Healing time is accelerated, providing faster epithetic rehabilitation without visible scars, which is important in the postoperative rehabilitation ladder after eye exenteration for both patient and surgeon. Further more ablative surgery within this region gets safer and easier due to the ample exposure of this innovative surgical technique. Further evaluation of the effectiveness and safety of this new approach is advisable. 相似文献